价格

Approvals/FDA/Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg

Approved

HUMAN PRESCRIPTION DRUG LABEL

cf4e5daae37fcc81

Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg

Major Pharmaceuticals🇺🇸 United States

FDA Page

Effective Date: Aug 19, 2026
Approval ID: a6e652e1-b2e4-47ba-bed2-c5e902f8b8f1
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES safely and effectively. See full prescribing information for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES. ASPIRIN and extended-release DIPYRIDAMOLE capsules, for oral useInitial U.S. Approval: 1999

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.